[
  {
    "ts": null,
    "headline": "Diald AI Announces Partnership with Moody’s",
    "summary": "LOS ANGELES, September 10, 2025--Diald AI, the first-of-its-kind proptech company delivering end-to-end, institutional-grade commercial real estate analysis in hours instead of weeks or months, today announced it has entered into a commercial partnership with Moody’s, integrating a trusted and quantitative data layer into the Diald platform. The new partnership combines Diald’s proprietary, patent‑pending qualitative analysis with Moody’s rigorous data foundation to deliver a holistic, credible,",
    "url": "https://finnhub.io/api/news?id=c974088985f08e8a9799b3a2d748a52700b001ea6f40da69309214c339e8f050",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1757513580,
      "headline": "Diald AI Announces Partnership with Moody’s",
      "id": 136689764,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MCO",
      "source": "Yahoo",
      "summary": "LOS ANGELES, September 10, 2025--Diald AI, the first-of-its-kind proptech company delivering end-to-end, institutional-grade commercial real estate analysis in hours instead of weeks or months, today announced it has entered into a commercial partnership with Moody’s, integrating a trusted and quantitative data layer into the Diald platform. The new partnership combines Diald’s proprietary, patent‑pending qualitative analysis with Moody’s rigorous data foundation to deliver a holistic, credible,",
      "url": "https://finnhub.io/api/news?id=c974088985f08e8a9799b3a2d748a52700b001ea6f40da69309214c339e8f050"
    }
  },
  {
    "ts": null,
    "headline": "Sabra Health Care REIT, Inc. Upgraded to Investment Grade Rating of Baa3 by Moody’s",
    "summary": "TUSTIN, Calif., September 10, 2025--Sabra Health Care REIT, Inc. (\"Sabra\") (Nasdaq: SBRA) announced today that Moody’s Ratings (\"Moody’s\") upgraded Sabra’s senior unsecured notes rating to \"Baa3\" from \"Ba1\", reflecting Sabra’s continued strong operating performance and prudent financial management. In conjunction with this upgrade, Moody’s has also assigned a \"Baa3\" issuer rating to Sabra, with a Stable outlook.",
    "url": "https://finnhub.io/api/news?id=777891b7fb7c1f52b0914dd5b99c2a74a5d045ec1b735e7cb3769b3d891927a6",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1757505600,
      "headline": "Sabra Health Care REIT, Inc. Upgraded to Investment Grade Rating of Baa3 by Moody’s",
      "id": 136689765,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MCO",
      "source": "Yahoo",
      "summary": "TUSTIN, Calif., September 10, 2025--Sabra Health Care REIT, Inc. (\"Sabra\") (Nasdaq: SBRA) announced today that Moody’s Ratings (\"Moody’s\") upgraded Sabra’s senior unsecured notes rating to \"Baa3\" from \"Ba1\", reflecting Sabra’s continued strong operating performance and prudent financial management. In conjunction with this upgrade, Moody’s has also assigned a \"Baa3\" issuer rating to Sabra, with a Stable outlook.",
      "url": "https://finnhub.io/api/news?id=777891b7fb7c1f52b0914dd5b99c2a74a5d045ec1b735e7cb3769b3d891927a6"
    }
  }
]